Gerrish S P, Goiti J J, Hunsley J E
Department of Cardiothoracic Surgery, Northern General Hospital, Sheffield, UK.
Eur J Cardiothorac Surg. 1988;2(6):438-41. doi: 10.1016/1010-7940(88)90048-6.
Oxygenated crystalloid cardioplegia was found not to produce better cardioprotection than blood or crystalloid cardioplegia, as assessed by myoglobin and creatine kinase MB (CPK-MB) isoenzyme, in patients undergoing coronary artery surgery. Myoglobin and CPK-MB levels were found to peak at 1 and 3 h, respectively, following release of the aortic cross-clamp. There was a good correlation between peak myoglobin and CPK-MB levels. CPK-MB of non-cardiac origin was found to represent a substantial proportion of total CPK-MB 4 h after the release of the aortic cross-clamp.
在接受冠状动脉手术的患者中,通过肌红蛋白和肌酸激酶MB(CPK-MB)同工酶评估发现,氧合晶体心脏停搏液在心脏保护方面并不比血液或晶体心脏停搏液更好。肌红蛋白和CPK-MB水平分别在主动脉阻断钳松开后1小时和3小时达到峰值。峰值肌红蛋白水平与CPK-MB水平之间存在良好的相关性。发现非心脏来源的CPK-MB在主动脉阻断钳松开后4小时占总CPK-MB的很大比例。